Onyx @ Union Square: Shankar Musunuri, CEO, Ocugen
What if the key to curing blindness wasn't targeting individual genes, but entire genetic networks?
2 stories
Make us preferred on GoogleWhat if the key to curing blindness wasn't targeting individual genes, but entire genetic networks?
“The cost of gene therapies can reach millions of dollars per patient… Our goal is developing cost-effective treatments that can be accessible globally.”
London · 15–19 November 2026
Explore Onyx’s independent guide to the events and make the most of your week in London.